Molecular defects found in some patients considered to have CVID
| Defect type . | Result . |
|---|---|
| Underlying B-cell defects | |
| Defective B-cell cytoplasmic second messengers (Btk)121 | X-linked agammaglobulinemia |
| Deletions in immunoglobulin genes122 | |
| Underlying T-cell defects | |
| Defective T-cell surface receptors (CD40L)123 | CD40L deficiency |
| Defective T-cell cytoplastic second messengers (lck, SAP)124 125 | X-linked lymphoproliferative disease, SCID (forme fruste) |
| Defective cell cycling, DNA repair enzymes126 | Ataxia-telangiectasia, Nijmegen breakage syndrome |
| Defective purine salvage pathway metabolism127 | ADA, PNP deficiency |
| Defect type . | Result . |
|---|---|
| Underlying B-cell defects | |
| Defective B-cell cytoplasmic second messengers (Btk)121 | X-linked agammaglobulinemia |
| Deletions in immunoglobulin genes122 | |
| Underlying T-cell defects | |
| Defective T-cell surface receptors (CD40L)123 | CD40L deficiency |
| Defective T-cell cytoplastic second messengers (lck, SAP)124 125 | X-linked lymphoproliferative disease, SCID (forme fruste) |
| Defective cell cycling, DNA repair enzymes126 | Ataxia-telangiectasia, Nijmegen breakage syndrome |
| Defective purine salvage pathway metabolism127 | ADA, PNP deficiency |
SCID indicates severe combined immunodeficiency; ADA, adenosine deaminase; and PNP, purine nucleoside phosphorylase. For explanation of other abbreviations, see Tables 1 and 3.